Follow
David S Tan
Title
Cited by
Cited by
Year
ESMO-ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Disease
EEOCCCWG N. Colombo, C. Sessa, A. du Bois, J. Ledermann, W.G. McCluggage, I ...
Int J Gynecol Cancer, 2019
1027*2019
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
EEOCCCWG N. Colombo, C. Sessa, A. du Bois, J. Ledermann, W.G. McCluggage, I ...
Annals of Oncology 30 (5), 672-705, 2019
10272019
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
E Kipps, DSP Tan, SB Kaye
Nature Reviews Cancer 13 (4), 273-282, 2013
5792013
“BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and …
DSP Tan, C Rothermundt, K Thomas, E Bancroft, R Eeles, S Shanley, ...
Journal of Clinical Oncology 26 (34), 5530-5536, 2008
5582008
Mechanisms of transcoelomic metastasis in ovarian cancer
DSP Tan, R Agarwal, SB Kaye
The lancet oncology 7 (11), 925-934, 2006
5302006
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
B Weigelt, A Mackay, R A'hern, R Natrajan, DSP Tan, M Dowsett, ...
The lancet oncology 11 (4), 339-349, 2010
4742010
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
DSP Tan, C Marchió, RL Jones, K Savage, IE Smith, M Dowsett, ...
Breast cancer research and treatment 111, 27-44, 2008
4382008
Biomarkers for homologous recombination deficiency in cancer
MM Hoppe, R Sundar, DSP Tan, AD Jeyasekharan
JNCI: Journal of the National Cancer Institute 110 (7), 704-713, 2018
2792018
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis
C Marchio, MB Lambros, P Gugliotta, LV Di Cantogno, C Botta, B Pasini, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
2262009
Are triple-negative tumours and basal-like breast cancer synonymous?
EA Rakha, DSP Tan, WD Foulkes, IO Ellis, A Tutt, TO Nielsen, ...
Breast cancer research 9, 1-3, 2007
1902007
Tiling path genomic profiling of grade 3 invasive ductal breast cancers
R Natrajan, MB Lambros, SM Rodríguez-Pinilla, G Moreno-Bueno, ...
Clinical Cancer Research 15 (8), 2711-2722, 2009
1882009
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
R Natrajan, B Weigelt, A Mackay, FC Geyer, A Grigoriadis, DSP Tan, ...
Breast cancer research and treatment 121, 575-589, 2010
1832010
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
E Arriola, C Marchio, DSP Tan, SC Drury, MB Lambros, R Natrajan, ...
Laboratory investigation 88 (5), 491-503, 2008
1832008
Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies
AL Wong, RA Soo, DS Tan, SC Lee, JS Lim, PC Marban, LR Kong, ...
Annals of Oncology 26 (5), 998-1005, 2015
1812015
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas
DSP Tan, MBK Lambros, S Rayter, R Natrajan, R Vatcheva, Q Gao, ...
Clinical cancer research 15 (7), 2269-2280, 2009
1812009
First-in-human trial of the oral ataxia telangiectasia and RAD3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumors
TA Yap, DSP Tan, A Terbuch, R Caldwell, C Guo, BC Goh, V Heong, ...
Cancer discovery 11 (1), 80-91, 2021
1642021
Ovarian clear cell adenocarcinoma: a continuing enigma
DSP Tan, S Kaye
Journal of clinical pathology 60 (4), 355-360, 2007
1632007
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement
A Mackay, B Weigelt, A Grigoriadis, B Kreike, R Natrajan, R A’hern, ...
JNCI: Journal of the National Cancer Institute 103 (8), 662-673, 2011
1592011
Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomas
DSP Tan, M Iravani, WG McCluggage, MBK Lambros, F Milanezi, ...
Clinical Cancer Research 17 (6), 1521-1534, 2011
1542011
Weekly paclitaxel in the treatment of recurrent ovarian cancer
RD Baird, DSP Tan, SB Kaye
Nature reviews Clinical oncology 7 (10), 575-582, 2010
1182010
The system can't perform the operation now. Try again later.
Articles 1–20